Cancer Research AACR Conference on Molecular Diagnostics - 2008  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schaper, I. D.
Right arrow Articles by Pfister, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schaper, I. D.
Right arrow Articles by Pfister, H.
[Cancer Research 65, 1394-1400, February 15, 2005]
© 2005 American Association for Cancer Research


Cell and Tumor Biology

Development of Skin Tumors in Mice Transgenic for Early Genes of Human Papillomavirus Type 8

Inke Diana Schaper1,4, Gian Paolo Marcuzzi1,4, Sönke Jan Weissenborn1,4, Hans Udo Kasper2, Volker Dries2, Neil Smyth3,4, Pawel Fuchs1 and Herbert Pfister1,4

1 Institute of Virology, 2 Department of Pathology, 3 Institute of Biochemistry, and 4 Center for Molecular Medicine Cologne, University of Cologne, Germany

Request for reprints: Herbert Pfister, Institute of Virology, University of Cologne, Fürst-Pückler-Straße 56 50935, Cologne, Germany. Phone: 49-221-4783901; Fax: 49-221-478-3902; E-mail: herbert.pfister{at}medizin.uni-koeln.de.

The cutaneous human papillomavirus (HPV) 8 is clearly involved in skin cancer development in epidermodysplasia verruciformis patients and its early genes E2, E6, and E7 have been implicated in cell transformation in vitro. To examine the functions of these genes in vivo we integrated the complete early region of HPV8 into the genome of DBA/Bl6 mice. To target their expression to the basal layer of the squamous epithelia the transgenes were put under the control of the keratin-14 promoter. Transgenic mice were back-crossed for up to six generations into both FVB/N and Bl6 mouse strains. Whereas none of the HPV8 transgene–negative littermates developed lesions in the skin or any other organ, 91% of HPV8-transgenic mice developed single or multifocal benign tumors, characterized by papillomatosis, acanthosis, hyperkeratosis, and varying degrees of epidermal dysplasia. Squamous cell carcinomas developed in 6% of the transgenic FVB/N mice. Real-time reverse transcription-PCR showed highest expression levels for HPV8-E2, followed by E7 and E6. There was no consistent difference in relative viral RNA levels between healthy or dysplastic skin and malignant skin tumors. Whereas UV-induced mutations in the tumor suppressor gene p53 are frequently detected in human skin carcinomas, mutations in p53 were not observed either in the benign or malignant mouse tumors. Nonmelanoma skin cancer developed in HPV8-transgenic mice without any treatment with physical or chemical carcinogens. This is the first experimental proof of the carcinogenic potential of an epidermodysplasia verruciformis–associated HPV-type in vivo.

Key Words: human papillomavirus • epidermodysplasia verruciformis • transgenic mice • 00-00-21 Melanoma/skin cancers • 01-01-14 Animal/in vitro models for carcinogenesis • 12-01-01 Human tumor viruses • 12-01-02 DNA tumor viruses • 12-01-04 Viral transformation and carcinogenesis




This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
L. Struijk, E. van der Meijden, S. Kazem, J. ter Schegget, F. R. de Gruijl, R. D. M. Steenbergen, and M. C. W. Feltkamp
Specific betapapillomaviruses associated with squamous cell carcinoma of the skin inhibit UVB-induced apoptosis of primary human keratinocytes
J. Gen. Virol., September 1, 2008; 89(9): 2303 - 2314.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. M. Bedard, M. P. Underbrink, H. L. Howie, and D. A. Galloway
The E6 Oncoproteins from Human Betapapillomaviruses Differentially Activate Telomerase through an E6AP-Dependent Mechanism and Prolong the Lifespan of Primary Keratinocytes
J. Virol., April 15, 2008; 82(8): 3894 - 3902.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A.-S. Gabet, R. Accardi, A. Bellopede, S. Popp, P. Boukamp, B. S. Sylla, J. A. Londono-Vallejo, and M. Tommasino
Impairment of the telomere/telomerase system and genomic instability are associated with keratinocyte immortalization induced by the skin human papillomavirus type 38
FASEB J, February 1, 2008; 22(2): 622 - 632.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
J. Nafz, A. Kohler, M. Ohnesorge, I. Nindl, E. Stockfleth, and F. Rosl
Persistence of Mastomys natalensis papillomavirus in multiple organs identifies novel targets for infection
J. Gen. Virol., October 1, 2007; 88(10): 2670 - 2678.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. F.L. O'Shaughnessy, B. Akgul, A. Storey, H. Pfister, C. A. Harwood, and C. Byrne
Cutaneous Human Papillomaviruses Down-regulate AKT1, whereas AKT2 Up-regulation and Activation Associates with Tumors
Cancer Res., September 1, 2007; 67(17): 8207 - 8215.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Queille, L. Luron, A. Spatz, M. F. Avril, V. Ribrag, P. Duvillard, C. Hiesse, A. Sarasin, J. P. Armand, and L. Daya-Grosjean
Analysis of skin cancer risk factors in immunosuppressed renal transplant patients shows high levels of UV-specific tandem CC to TT mutations of the p53 gene
Carcinogenesis, March 1, 2007; 28(3): 724 - 731.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Michel, A. Kopp-Schneider, H. Zentgraf, A. D. Gruber, and E.-M. de Villiers
E6/E7 Expression of Human Papillomavirus Type 20 (HPV-20) and HPV-27 Influences Proliferation and Differentiation of the Skin in UV-Irradiated SKH-hr1 Transgenic Mice
J. Virol., November 15, 2006; 80(22): 11153 - 11164.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Muller-Schiffmann, J. Beckmann, and G. Steger
The e6 protein of the cutaneous human papillomavirus type 8 can stimulate the viral early and late promoters by distinct mechanisms.
J. Virol., September 1, 2006; 80(17): 8718 - 8728.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
I. Semkova, S. Fauser, A. Lappas, N. Smyth, N. Kociok, B. Kirchhof, M. Paulsson, V. Poulaki, and A. M. Joussen
Overexpression of FasL in retinal pigment epithelial cells reduces choroidal neovascularization
FASEB J, August 1, 2006; 20(10): 1689 - 1691.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
M. de Koning, W. Quint, L. Struijk, B. Kleter, P. Wanningen, L.-J. van Doorn, S. J. Weissenborn, M. Feltkamp, and J. ter Schegget
Evaluation of a Novel Highly Sensitive, Broad-Spectrum PCR-Reverse Hybridization Assay for Detection and Identification of Beta-Papillomavirus DNA.
J. Clin. Microbiol., May 1, 2006; 44(5): 1792 - 1800.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
W. Dong, U. Kloz, R. Accardi, S. Caldeira, W.-M. Tong, Z.-Q. Wang, L. Jansen, M. Durst, B. S. Sylla, L. Gissmann, et al.
Skin Hyperproliferation and Susceptibility to Chemical Carcinogenesis in Transgenic Mice Expressing E6 and E7 of Human Papillomavirus Type 38
J. Virol., December 1, 2005; 79(23): 14899 - 14908.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P. Boukamp
Non-melanoma skin cancer: what drives tumor development and progression?
Carcinogenesis, October 1, 2005; 26(10): 1657 - 1667.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.